Pro Health Tips
Friday, 22 October 2021
Impact of Breakthrough Therapy Designed for Alzheimer's Disease Treatment
Alzheimer's disease treatment gantenerumab is set to generate (Dollar) 2.2bn by 2030, as the first subcutaneously administered therapy to enter the global market.
from Medindia Health News https://ift.tt/3C1jpYd
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Alzheimer's disease treatment gantenerumab is set to generate (Dollar) 2.2bn by 2030, as the first subcutaneously administered therapy to enter the global market.
No comments:
Post a Comment